General News

RMS Receives FDA Clearance for 510(k)

RMS Freedom Infusion System Cleared for Both Subcutaneous and Intravenous Indications CHESTER, NY / September 05, 2017 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) announces the FDA issued a new 510(k) clearance for the RMS “Integrated Catch-Up Freedom Syringe Driver Infusion System” effective August 31, 2017.  The Freedom System is the … Continued

RMS Launches New Social Media Campaign

CHESTER, NY / May 15, 2017 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) (“RMS” or the “Company”) announced today it will be launching a new social media marketing campaign at the National Home Infusion Association (NHIA) in Orlando Florida on May 22, 2017.  NHIA is one of the largest U.S. tradeshows … Continued

RMS Medical Products launches FREEDOM60® Infusion system in Germany

CHESTER, NY / April 10, 2017 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) (“RMS” or the “Company”) is pleased to announce that the umbrella organization of the public health insurance in Germany approved the FREEDOM60® Infusion System for reimbursement. The FREEDOM60® System was registered January, 31st 2017 and listed in the … Continued

Investor Updates

RMS April 23, 2018 Annual Shareholder Meeting Presentation

2017 Breakthrough Year Highlights Highest Reported Twelve Month Net Sales and Net Income in RMS History 25% Increase in Net Sales 21% Increase in Gross Profit 12% Decrease in Operating Expenses as % of Net Sales 7% Increase in Net Income as % of Net Sales

Daniel Goldberger Nominated for Election to RMS Board of Directors

CHESTER, NY / March 14, 2018 / The Board of Directors of Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) today announced that seasoned senior executive and business leader Daniel Goldberger has been nominated to stand for election to the board at the Company’s Annual Meeting of Shareholders on April 23, 2018, replacing … Continued

RMS Proxy Statement 14(a) March 2018

Notice of Annual Meeting of Shareholders To Be Held April 23, 2018 The 2018 Annual Meeting of Shareholders (the “Annual Meeting”) of Repro Med Systems, Inc. (the “Company”) will be held on April 23, 2018 at 3:00 p.m. Eastern Standard Time at the Company’s Corporate Offices located at 24 Carpenter Road, Chester, New York, 10918, … Continued

RMS Announces Results for Three, Ten and Twelve Months Ending December 31, 2017

Highest reported twelve month net sales and net income in RMS history Double digit percentage growth in net sales Increased profitability CHESTER, NY / February 13, 2018 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) today announced the latest financial results for the three, ten and twelve months ending December 31, 2017. … Continued